These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 20173787

  • 1. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.
    Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S, Fechter M, Greinix H, Koh M, Lee S, Nicoloso-De-Faveri G, Philippe J, Pollichieni S, Pulsipher M, Schmidt A, Yang E, van Walraven AM, Clinical Working Group, Ethics Working Group of the WMDA.
    Bone Marrow Transplant; 2010 May; 45(5):832-8. PubMed ID: 20173787
    [Abstract] [Full Text] [Related]

  • 2. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.
    Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M, Donor Registries Working Group of the World Marrow Donor Association (WMDA).
    Bone Marrow Transplant; 2010 May; 45(5):811-8. PubMed ID: 20154736
    [Abstract] [Full Text] [Related]

  • 3. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.
    Hurley CK, Foeken L, Horowitz M, Lindberg B, McGregor M, Sacchi N, WMDA Accreditation and Regulatory Committees.
    Bone Marrow Transplant; 2010 May; 45(5):819-24. PubMed ID: 20173794
    [Abstract] [Full Text] [Related]

  • 4. Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products.
    Maiers M, Bakker JN, Bochtler W, Eberhard HP, Marsh SG, Müller C, Rist HG, Information Technology Working Group (ITWG) of the WMDA.
    Bone Marrow Transplant; 2010 May; 45(5):839-42. PubMed ID: 20190838
    [Abstract] [Full Text] [Related]

  • 5. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.
    Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A, Greinix H, Quality Assurance and Clinical Working Groups of the World Marrow Donor Association.
    Bone Marrow Transplant; 2008 Jul; 42(1):9-14. PubMed ID: 18362904
    [Abstract] [Full Text] [Related]

  • 6. International exchange of cord blood units: the registry aspects.
    Welte K, Foeken L, Gluckman E, Navarrete C, Cord Blood Working Group of the World Marrow Donor Association.
    Bone Marrow Transplant; 2010 May; 45(5):825-31. PubMed ID: 20190837
    [Abstract] [Full Text] [Related]

  • 7. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.
    Hurley CK, Raffoux C, World Marrow Donor Association.
    Bone Marrow Transplant; 2004 Jul; 34(2):103-10. PubMed ID: 15170173
    [Abstract] [Full Text] [Related]

  • 8. A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).
    Wiegand T, Raffoux C, Hurley CK, Kern M, Oudshoorn M, Raymond J, Cleaver S, Marry E, Muller C, World Marrow Donor Association Quality Assurance Work Group, WMDA Donor Registries Working Group.
    Bone Marrow Transplant; 2004 Jul; 34(2):97-101. PubMed ID: 15170174
    [Abstract] [Full Text] [Related]

  • 9. The World Marrow Donor Association (WMDA): its goals and activities.
    Gahrton G, van Rood JJ, Oudshoorn M, World Marrow Donor Association (WMDA).
    Bone Marrow Transplant; 2003 Jul; 32(2):121-4. PubMed ID: 12838274
    [Abstract] [Full Text] [Related]

  • 10. Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association.
    Boo M, van Walraven SM, Chapman J, Lindberg B, Schmidt AH, Shaw BE, Switzer GE, Yang E, Egeland T, World Marrow Donor Association.
    Blood; 2011 Jan 06; 117(1):21-5. PubMed ID: 20921337
    [Abstract] [Full Text] [Related]

  • 11. The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation.
    Petersdorf EW.
    Bone Marrow Transplant; 2010 May 06; 45(5):807-10. PubMed ID: 20190834
    [Abstract] [Full Text] [Related]

  • 12. WMDA guidelines for subsequent donations following initial BM or PBSCs.
    Confer DL, Shaw BE, Pamphilon DH, Clinical Working Group of the WMDA.
    Bone Marrow Transplant; 2011 Nov 06; 46(11):1409-12. PubMed ID: 21297674
    [Abstract] [Full Text] [Related]

  • 13. Donor and liability insurance of donor registries, donor centers, and collection centers--recommendations.
    Egeland T, Lie J, Persson U, Raymond J, Müller C, World Marrow Donor Association Ethics Working Group.
    Bone Marrow Transplant; 2004 Mar 06; 33(5):467-70. PubMed ID: 14688817
    [Abstract] [Full Text] [Related]

  • 14. Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.
    Rosenmayr A, Hartwell L, Egeland T, Ethics Working Group of the World Marrow Donor Association.
    Bone Marrow Transplant; 2003 Apr 06; 31(7):539-45. PubMed ID: 12692618
    [Abstract] [Full Text] [Related]

  • 15. Unrelated hematopoietic stem cell donors as research subjects.
    King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH, Costeas P, Shaw B, Egeland T, Ethics and Clinical Working Groups of World Marrow Donor Association.
    Bone Marrow Transplant; 2011 Jan 06; 46(1):10-3. PubMed ID: 20190845
    [Abstract] [Full Text] [Related]

  • 16. Family donor care management: principles and recommendations.
    van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UA, Douglas KW, Jones DA, Lee SJ, Pulsipher M, Ritchie L, Halter J, Shaw BE, WMDA Ethics and Clinical working groups.
    Bone Marrow Transplant; 2010 Aug 06; 45(8):1269-73. PubMed ID: 20023708
    [Abstract] [Full Text] [Related]

  • 17. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD, Hartzman RJ, Perry EH, Trainor L, Miller J, Miller R, Hanley L, Chitphakdithai P, King RJ.
    Biol Blood Marrow Transplant; 2008 Sep 06; 14(9 Suppl):23-8. PubMed ID: 18721777
    [Abstract] [Full Text] [Related]

  • 18. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
    Dodson KL, Coppo PA, Confer DL.
    Clin Transpl; 1999 Sep 06; ():121-7. PubMed ID: 11038630
    [Abstract] [Full Text] [Related]

  • 19. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
    Pulsipher MA, Nagler A, Iannone R, Nelson RM.
    Pediatr Blood Cancer; 2006 Apr 06; 46(4):422-33. PubMed ID: 16411207
    [Abstract] [Full Text] [Related]

  • 20. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
    Bitan M, van Walraven SM, Worel N, Ball LM, Styczynski J, Torrabadella M, Witt V, Shaw BE, Seber A, Yabe H, Greinix HT, Peters C, Gluckman E, Rocha V, Halter J, Pulsipher MA.
    Biol Blood Marrow Transplant; 2016 Jan 06; 22(1):96-103. PubMed ID: 26307344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.